March 15, 2026 - 20:51

In his final years at the helm of Berkshire Hathaway, Warren Buffett executed a strategy that stood in stark contrast to the exuberance on Wall Street. While markets celebrated record highs, the legendary investor was steadily building the conglomerate's cash reserves to a staggering $373 billion and became a net seller of equities.
This massive accumulation of cash, which Buffett himself described as a "war chest," signals a profound lack of compelling investment opportunities in the eyes of the Oracle of Omaha. His actions suggest he viewed the market as overvalued, preferring the safety and flexibility of liquidity over deploying capital at inflated prices. This conservative posture from history’s most successful long-term investor serves as a potent cautionary tale.
The move underscores Buffett’s timeless principle of being "fearful when others are greedy." His disciplined refusal to chase overpriced assets, even amid widespread optimism, leaves a clear message for investors: sustaining such high market valuations requires exceptional business growth, which may not be forthcoming. This record cash pile is not merely a balance sheet figure; it is a $373 billion question mark over the current market's durability.
September 12, 2026 - 00:50
US Tariff Refunds Slow as Government Collects More Than It Pays OutThe flow of tariff refunds from the US government has slowed sharply, with new figures showing the Treasury took in more money from tariffs than it returned to importers for the first time in...
September 11, 2026 - 02:46
Rayonier Advanced Materials’ (RYAM) Pricing Power Is Surging, But Volumes Tell Another StoryRayonier Advanced Materials reported second-quarter results on August 4 for the period ending June 27, showing a mixed picture of financial performance. Net sales reached $376 million, an 18...
September 10, 2026 - 21:54
OpenAI Rolls Out ChatGPT for Financial Services With Major Industry PartnersOpenAI has introduced a version of ChatGPT built specifically for the financial sector, teaming up with several large brokerages and research organizations, including Morgan Stanley and S&P. The...
September 10, 2026 - 04:58
InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate UpdateVancouver-based InMed Pharmaceuticals has released its financial results for the full fiscal year that ended on June 30, 2026, alongside a broader update on its corporate activities. The company,...